Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Castle Biosciences Inc (NQ: CSTL ) 33.15 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Castle Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Castle Biosciences Presents Award-Winning Abstract at ACG 2024 Demonstrating Ability of Its TissueCypher® Test to Significantly Reduce Healthcare Costs Associated with the Management of Barrett’s Esophagus Patients October 29, 2024 From Castle Biosciences Inc. Via Business Wire The Analyst Landscape: 4 Takes On Castle Biosciences October 29, 2024 Via Benzinga Momentum Has Narrowed Again, Significantly October 28, 2024 It is more of a stock pickers market than usual as momentum factors are currently exaggerated. Via Talk Markets Castle Biosciences to Participate in Upcoming Investor Conferences October 28, 2024 From Castle Biosciences Inc. Via Business Wire Sotera Health Stock Earns 91 RS Rating September 10, 2024 On Tuesday, Sotera Health stock hit a key technical milestone, with its Relative Strength Rating climbing to 91, up from 86 the day before. Via Investor's Business Daily Castle Biosciences Presents New Data at ASDS from Prospective, Multicenter CONNECTION Study Supporting Use of DecisionDx®-Melanoma to Guide SLNB Decisions in T1a Tumors with High-Risk Features and T1b Tumors October 20, 2024 From Castle Biosciences Inc. Via Business Wire Recent Publications Affirm the Value of Gene Expression Profile Testing in Guiding a Definitive Diagnosis and Clinical Decision-Making in Melanocytic Lesions of Uncertain Malignant Potential October 16, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences to Release Third Quarter 2024 Financial Results and Host Conference Call on Monday, Nov. 4, 2024 October 14, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences to Support the 71st Annual Montagna Symposium on the Biology of the Skin October 11, 2024 From Castle Biosciences Inc. Via Business Wire New Prospective, Multicenter Study Presented at SMR Demonstrates Castle Biosciences’ DecisionDx®-Melanoma Test Provides Significant Risk Prediction for Patients with Cutaneous Melanoma, Adding Value to Current Stage-Based Treatment Pathway Decisions October 09, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences Hosts Groundbreaking Ceremony at Site of New Corporate Headquarters in Friendswood, Texas October 02, 2024 From Castle Biosciences Inc. Via Business Wire New Data at ASTRO 2024 Shows Castle Biosciences’ DecisionDx®-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma September 27, 2024 From Castle Biosciences Inc. Via Business Wire New Data at AFS 2024 Demonstrates the Strength of Castle Biosciences’ TissueCypher® Test in Independently Predicting Risk of Developing Esophageal Cancer, Guiding Risk-Aligned Management Decisions for Patients with Barrett’s Esophagus September 23, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year September 16, 2024 From Castle Biosciences Inc. Via Business Wire DecisionDx®-Melanoma Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who May Safely Forego Biopsy Surgery, New Independent Study Affirms September 11, 2024 From Castle Biosciences Inc. Via Business Wire Study Confirms the Ability of Castle Biosciences' DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma September 05, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences to Participate in Upcoming Investor Conferences August 28, 2024 From Castle Biosciences Inc. Via Business Wire Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday August 06, 2024 Via Benzinga CSTL Stock Earnings: Castle Biosciences Beats EPS, Beats Revenue for Q2 2024 August 05, 2024 CSTL stock results show that Castle Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Castle Biosciences Reports Second Quarter 2024 Results August 05, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference July 30, 2024 From Castle Biosciences Inc. Via Business Wire ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday July 29, 2024 Via Benzinga Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma July 22, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024 July 15, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences Honored with Top Workplaces Awards July 11, 2024 From Castle Biosciences Inc. Via Business Wire Top 5 Health Care Stocks That May Explode In July July 08, 2024 Via Benzinga Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 05, 2024 Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family Via Benzinga Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test June 24, 2024 From Castle Biosciences Inc. Via Business Wire Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 20, 2024 From Castle Biosciences Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session June 19, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
